Clinical trials in cancer part II. Biomedical, complementary, and alternative medicine: significant issues.
Lee
Colleen O
CO
Office of Complementary and Alternative Medicine at the National Cancer Institute in Bethesda, MD, USA. leeco@mail.nih.gov
D002986:Clinical Trials as Topic / Q000941:ethics / Q000379:methods / Q000451:nursing / Q000592:standards; D003131:Combined Modality Therapy; D000529:Complementary Therapies / Q000009:adverse effects / Q000193:education / Q000941:ethics / Q000451:nursing / Q000592:standards*; D019317:Evidence-Based Medicine; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D024802:Nurse's Role; D009859:Oncology Nursing / Q000193:education / Q000379:methods; D018579:Patient Selection / Q000941:ethics; D012107:Research Design / Q000592:standards